Biomedical Informatics Methods for Personalized Medicine and Participatory Health

Methods in Biomedical Informatics: A Pragmatic Approach

Volumn , Issue , 2013, Pages 347-394

  Martin Sanchez, Fernando ^a   Lopez Campos, Guillermo ^a   Gray, Kathleen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Association study; Biomedical informatics; Databases; EHR; Genomics; Participatory health; Patient engagement; Personalized medicine; PHR; Sensors

Indexed keywords

EID: 84902555949     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-401678-1.00011-7     Document Type: Chapter

References (100)

1. Clarke L, Zheng-Bradley X, Smith R, Kulesha E, Xiao C, Toneva I, et al. The 1000 Genomes Project: data management and community access. Nature Methods 2012, 9(5):459-462. Epub 2012/05/01.
2. Kozal MJ, Shah N, Shen N, Yang R, Fucini R, Merigan TC, et al. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med 1996, 2(7):753-759. Epub 1996/07/01.
3. Vahey M, Nau ME, Barrick S, Cooley JD, Sawyer R, Sleeker AA, et al. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol 1999, 37(8):2533-2537. Epub 1999/07/16.
4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98(19):10869-10874. Epub 2001/09/13.
5. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. New Engl J Med 2002, 347(25):1999-2009. Epub 2002/12/20.
6. Nadkarni PM, Ohno-Machado L, Chapman WW Natural language processing: an introduction. J Am Med Inform Assoc 2011, 18(5):544-551. Epub 2011/08/19.
7. Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF Extracting information from textual documents in the electronic health record: a review of recent research. Yearb Med Inform 2008, 128-144. Epub 2008/07/30.
8. Hripcsak G, Albers DJ Next-generation phenotyping of electronic health records. J Am Med Inform Assoc 2013, 20(1):117-121. Epub 2012/09/08.
9. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genom 2011, 4:13. Epub 2011/01/29.
10. Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N, et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med 2011, 3(79):79re1. Epub 2011/04/22.
11. Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, et al. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy 2008, 28(8):992-998. Epub 2008/07/29.
12. Johnson EG, Horne BD, Carlquist JF, Anderson JL Genotype-based dosing algorithms for warfarin therapy: data review and recommendations. Mol Diagn Ther 2011, 15(5):255-264. Epub 2011/11/04.
13. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. New Engl J Med 2009, 360(4):354-362. Epub 2008/12/25.
14. Thorn CF, Klein TE, Altman RB Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics 2010, 11(4):501-505. Epub 2010/03/31.
15. Kouris I, Tsirmpas C, Mougiakakou SG, Iliopoulou D, Koutsouris D. E-Health towards ecumenical framework for personalized medicine via Decision Support System. In: Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society; 2010. p. 2881-5. Epub 2010/11/26.
16. Leong TY Toward patient-centered, personalized and personal decision support and knowledge management: a survey. Yearb Med Inform 2012, 7(1):104-112. Epub 2012/08/15.
17. Overby CL, Tarczy-Hornoch P, Hoath JI, Kalet IJ, Veenstra DL Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support. BMC Bioinform 2010, 11(Suppl.9):S10. Epub 2012/11/10.
18. Pazzani MJ, See D, Schroeder E, Tilles J Application of an expert system in the management of HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15(5):356-362. Epub 1997/08/15.
19. Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, Gonzalez J, et al. Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS (London, England) 2002, 16(2):209-218. Epub 2002/01/25.
20. Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T Personalizing drug selection using advanced clinical decision support. Biomed Inform Insights 2009, 2:19-29. Epub 2009/11/10.
21. Deshmukh VG, Hoffman MA, Arnoldi C, Bray BE, Mitchell JA Efficiency of CYP2C9 genetic test representation for automated pharmacogenetic decision support. Methods Inf Med 2009, 48(3):282-290. Epub 2009/04/24.
22. Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Therapeut 2012, 92(1):87-95. Epub 2012/05/17.
23. Kohane IS Using electronic health records to drive discovery in disease genomics. Nat Rev Genet 2011, 12(6):417-428. Epub 2011/05/19.
24. Wild CP Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005, 14(8):1847-1850. Cosponsored by the American Society of Preventive Oncology. Epub 2005/08/17.
25. Wild CP The exposome: from concept to utility. Int J Epidemiol 2012, 41(1):24-32. Epub 2012/02/03.
26. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinogenesis 1999, 24(3):153-159. Epub 1999/04/16.
27. Davis AP, Wiegers TC, Rosenstein MC, Mattingly CJ MEDIC: a practical disease vocabulary used at the Comparative Toxicogenomics Database. Database: J Biol Databases Curation 2012, 2012:bar065. Epub 2012/03/22.
28. Stover PJ, Harlan WR, Hammond JA, Hendershot T, Hamilton CM PhenX: a toolkit for interdisciplinary genetics research. Curr Opin Lipidol 2010, 21(2):136-140. Epub 2010/02/16.
29. Vreeman DJ, McDonald CJ, Huff SM Representing patient assessments in LOINC(R). AMIA Annu Sympos Proc 2010, 2010:832-836. Epub 2011/02/25.
30. Hamilton CM, Strader LC, Pratt JG, Maiese D, Hendershot T, Kwok RK, et al. The PhenX Toolkit: get the most from your measures. Am J Epidemiol 2011, 174(3):253-260. Epub 2011/07/14.
31. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010, 39(5):1383-1393. Epub 2010/09/04.
32. Fortier I, Doiron D, Burton P, Raina P Invited commentary: consolidating data harmonization - how to obtain quality and applicability?. Am J Epidemiol 2011, 174(3):261-264. author reply 5-6, Epub 2011/07/14.
33. Chervitz SA, Deutsch EW, Field D, Parkinson H, Quackenbush J, Rocca-Serra P, et al. Data standards for Omics data: the basis of data sharing and reuse. Methods Mol Biol (Clifton, NJ) 2011, 719:31-69. Epub 2011/03/04.
34. Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, Ashburner M, et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 2008, 26(8):889-896. Epub 2008/08/09.
35. Sansone SA, Rocca-Serra P, Brandizi M, Brazma A, Field D, Fostel J, et al. The first RSBI (ISA-TAB) workshop: can a simple format work for complex studies?. Omics: J Integr Biol 2008, 12(2):143-149. Epub 2008/05/02.
36. Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 2012, 30(11):1033-1036. Epub 2012/11/10.
37. Bohannon J Genealogy databases enable naming of anonymous DNA donors. Science 2013, 339(6117):262. Epub 2013/01/18.
38. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008, 4(8):e1000167. Epub 2008/09/05.
39. Cassa CA, Miller RA, Mandl KD A novel, privacy-preserving cryptographic approach for sharing sequencing data. J Am Med Inform Assoc 2013, 20(1):69-76. Epub 2012/11/06.
40. Ball MP, Thakuria JV, Zaranek AW, Clegg T, Rosenbaum AM, Wu X, et al. A public resource facilitating clinical use of genomes. Proc Natl Acad Sci USA 2012, 109(30):11920-11927. Epub 2012/07/17.
41. Reich DE, Lander ES On the allelic spectrum of human disease. Trends Genet 2001, 17(9):502-510. Epub 2001/08/30.
42. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753. Epub 2009/10/09.
43. Moore JH, Williams SM New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002, 34(2):88-95. Epub 2002/07/11.
44. Aschard H, Lutz S, Maus B, Duell EJ, Fingerlin TE, Chatterjee N, et al. Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Human Genet 2012, 131(10):1591-1613. Epub 2012/07/05.
45. Moore JH Detecting, characterizing, and interpreting nonlinear gene-gene interactions using multifactor dimensionality reduction. Adv Genet 2010, 72:101-116. Epub 2010/10/30.
46. Gunther F, Wawro N, Bammann K Neural networks for modeling gene-gene interactions in association studies. BMC Genet 2009, 10:87. Epub 2009/12/25.
47. Robnik-Sikonja M, Cukjati D, Kononenko I Comprehensible evaluation of prognostic factors and prediction of wound healing. Artif Intell Med 2003, 29(1-2):25-38. Epub 2003/09/06.
48. Greene CS, Penrod NM, Kiralis J, Moore JH Spatially uniform relieff (SURF) for computationally-efficient filtering of gene-gene interactions. BioData Mining 2009, 2(1):5. Epub 2009/09/24.
49. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Mol Genet 2009, 18(11):2078-2090. Epub 2009/03/17.
50. Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci USA 2012, 109(18):7049-7054. Epub 2012/04/14.
51. Rakyan VK, Down TA, Balding DJ, Beck S Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12(8):529-541. Epub 2011/07/13.
52. Beyan H, Down TA, Ramagopalan SV, Uvebrant K, Nilsson A, Holland ML, et al. Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome Res 2012, 22(11):2138-2145. Epub 2012/08/25.
53. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453(7193):396-400. Epub 2008/04/22.
54. Nicholson JK, Holmes E, Elliott P The metabolome-wide association study: a new look at human disease risk factors. J Proteome Res 2008, 7(9):3637-3638. Epub 2008/08/19.
55. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T, et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 2008, 4(11):e1000282. Epub 2008/12/02.
56. Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics (Oxford, England) 2010, 26(9):1205-1210. Epub 2010/03/26.
57. Pendergrass SA, Brown-Gentry K, Dudek SM, Torstenson ES, Ambite JL, Avery CL, et al. The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol 2011, 35(5):410-422. Epub 2011/05/20.
58. Pendergrass SA, Dudek SM, Crawford DC, Ritchie MD Visually integrating and exploring high throughput Phenome-Wide Association Study (PheWAS) results using PheWAS-View. BioData Mining 2012, 5(1):5. Epub 2012/06/12.
59. Patel CJ, Bhattacharya J, Butte AJ An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PloS One 2010, 5(5):e10746. Epub 2010/05/28.
60. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 2009, 106(45):19096-19101. Epub 2009/10/29.
61. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I, et al. Whole-genome sequencing for optimized patient management. Sci Transl Med 2011, 3(87):87re3. Epub 2011/06/17.
62. Stein LD. An introduction to the informatics of "next-generation" sequencing. In: Baxevanis Andreas D et al. Current protocols in bioinformatics; 2011 [chapter 11]: Unit 11 1. Epub 2011/12/14.
63. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010, 20(9):1297-1303. Epub 2010/07/21.
64. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249. Epub 2010/04/01.
65. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012, 4(154):154ra135. Epub 2012/10/03.
66. Fuchs C. Knowledge and society from the perspective of the unified theory of information (UTI) approach. In: Petitjean M, editor. Proceedings of FIS2005: third conference on the foundations of information science, Paris, 4-7 July 2005. Molecular Diversity Preservation International (MDPI), Basel, Switzerland, [accessed 20.12.12]. http://www.mdpi.org/fis2005/F.24.paper.pdf.
67. Geist P, Dreyer J The demise of dialogue: a critique of medical encounter ideology. West J Commun 1993, 57(2):233-246.
68. Cahill J Patient participation - a review of the literature. J Clin Nursing 1998, 7:119-128.
69. Gawthrop L, Waldo D. Civis, civitas, and civilitas: a new focus for the year 2000. Public Administration Review 1984, 44 March 101-111.
70. Kruger J The patient will see you now. J Participatory Med 2011, 3. [accessed 03.05.12].
71. Wagholikar A, Fung M, Nelson C Improving self-care of patients with chronic disease using online personal health record. Austr Med J 2012, 5(9):517-521. 10.4066/AMJ.2012.1358>.
72. Santos C, Pedrosa T, Costa C, Oliveira JL Concepts for a personal health record. Stud Health Technol Inform 2012, 180:636-640.
73. Swan M Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking. Int J Environ Res Public Health 2009, 6(2):492-525.
74. Dyson E Why participatory medicine?. J Participatory Med 2009, 1(1):e1. [accessed 03.05.12].
75. Smarr L Quantifying your body: a how-to guide from a systems biology perspective. Biotechnol J 2012, 7(8):980-991.
76. Schneider GF, Dekker C DNA sequencing with nanopores. Nat Biotechnol 2012, 30(4):326-328.
77. Weaver M, Pollin TI Direct-to-consumer genetic testing: what are we talking about?. J Genet Couns 2012.
78. Karczewski KJ, Tirrell RP, Cordero P, Tatonetti NP, Dudley JT, Salari K, et al. Interpretome: a freely available, modular, and secure personal genome interpretation engine. Pac Sympos Biocomput 2012, 339-350.
79. Stead W Positioning the library at the epicentre of the networked biomedical enterprise. Bull Med Libr Assoc 1998, 86(1):26-30.
80. Fox S, Jones S The social life of health information. Pew Internet Am Life Project 2009, [accessed 03.05.12].
81. Laakso M, Bjork B-C Anatomy of open access publishing: a study of longitudinal development and internal structure. BMC Med 2012, 10(124):9.
82. Vardell E, Moore M Isabel, a clinical decision support system. Med Ref Serv Quart 2011, 30(2):158-166.
83. Delbanco T, Walker J, Darer JD, Elmore JG, Feldman HJ, Leveille SG, et al. Open notes: doctors and patients signing on. Ann Intern Med 2010, 153(2):121-125.
84. Vicdan Handan, Dholakia Nikhilesh. Medicine 2.0 and beyond: from information seeking to knowledge creation in virtual health communities (29 March 2012). Belk Russell W, Llamas Rosa, editors. The Routledge companion to digital consumption. New York and London: Routledge; 2012. Available at SSRN: [accessed 20.12.12]. http://ssrn.com/abstract=2030844.
85. Braddock CH The emerging importance and relevance of shared decision making to clinical practice. Med Decis Making 2010, 30(Suppl. 1):5S-7S.
86. Park S, Lee S, Kim M, Kim H Shared decision support system on dental restoration. Expert Syst Appl 2012, 39(14):11775-11781.
87. Cohen RM, Greenberg JM, Ishak WW Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the individual burden of illness index for depression to measure treatment impact and recovery in MDD. JAMA Psych 2013, 2:1-8.
88. Sugrue R, Macgregor G, Sugrue M, Curran S, Murphy L An evaluation of patient reported outcomes following breast reconstruction utilizing Breast Q. Breast 2013.
89. Bhumbra R Experts point out pitfalls of using patient reported outcomes to guide NHS care. BMJ 2012, (345):e8133.
90. Paz SH, Spritzer KL, Morales LS, Hays RD Evaluation of the Patient-Reported Outcomes Information System (PROMIS()) Spanish-language physical functioning items. Qual Life Res 2012, [Epub ahead of print] PubMed PMID: 23124505.
91. Cascade E, Marr P, Winslow M, Burgess A, Nixon M Conducting research on the Internet: medical record data integration with patient-reported outcomes. J Med Internet Res 2012, 14(5):e137.
92. Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E International Society for Quality of Life Research. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care 2012, 50(12):1060-1070.
93. Ohno-Machado L Informatics 2.0: implications of social media, mobile health, and patient-reported outcomes for healthcare and individual privacy. J Am Med Inform Assoc 2012, 19(5):683.
94. Hinds PS, Nuss SL, Ruccione KS, Withycombe JS, Jacobs S, Deluca H, et al. PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes. Pediatr Blood Cancer 2013, 60(3):402-408.
95. Swan M Scaling crowdsourced health studies: the emergence of a new form of contract research organization. Personal Med 2012, 9(2):223-234.
96. Silber D Medicine 2.0: the stakes of participatory medicine. Presse Med 2009, 38(10):1456-1462. [in French].
97. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011, 7(6).
98. Wicks P, Vaughan T, Massagli M, Heywood J Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotechnol 2011, 29:411-414.
99. Hood L, Friend S Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011, 8:184-187.
100. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148(6):1293-1307.